Global Operations Asset Leader; GOAL

Global Operations Asset Leader (GOAL) page is loaded## Global Operations Asset Leader (GOAL) locations:
Baseltime type:
Tempo integral posted on:
Publicado hojetime left to apply:
Data de término: 31 de janeiro de 2026 (14 dias restantes para se candida tar) job requisition :
Na Roche, você pode-se apresentar como você mesmo, abraçado pelas qualidades únicas que traz. Nossa cultura incentiva a expressão pessoal, o diálogo aberto e as conexões genuínas, onde você é valorizado e respeitado por quem você é, e permitindo que você prospere tanto pessoal como profissionalmente. É assim que pretend emos prevenir, deter e curar doenças e garantir que todos tenham acesso aos cuidados de saúde hoje e nas gerações futuras.

Junte-se à Roche, onde cada voz é importante.### A posiçãoAt Roche Pharma Product Development Global Clinical Operations (PDG), we are determined to transform drug development and realize our Pharma Ambition to deliver 20 transformative medicines addressing diseases with the highest societal burden by 2029. We are looking for a Global Operations Asset Leader to lead and drive the operational delivery of one (or more) of our assets.  

This people leadership position holds significant accountability for clinical operations strategy and execution as well as enterprise collaboration.

PD’s mission is to improve patients’ lives around the world through unique medicines that have a meaningful impact. Cross functionally we conduct global clinical trials, analyze results, monitor safety, and work with regulatory authorities to provide truly differentiated medicines to patients. Our primary disease focus areas are Oncology, Hematology, Neurology,  Immunology,  Ophthalmology, Cardiovascular, Renal, and Metabolism (CVRM).
We attract, develop, and retain the most talented people in the industry, within PDG’s  Clinical Operations Country Footprint.

The
** Global Operations Asset Leader (GOAL)
** in PDG at Roche is accountable and responsible  for the clinical operations delivery of one or more assets  in line with budget, timelines and quality expectations, including timely and accurate data entry in our systems  at both a study and asset level.  One asset comprises multiple clinical studies.

The GOAL is accountable for delivering an Asset’s portfolio of clinical studies  within a TA/DA through architecting and translating the overall operational strategy and business needs, in partnership with the appropriate Therapeutic Area and Disease Area Leaders, Country leaders and other key PDG and enterprise senior stakeholders. The Operations Asset Leader will represent the PDG perspective at the Global Development and Lifecycle Teams and will develop and continuously adapt the Asset strategy and tactics to ensure the overall clinical operations delivery meets or exceeds delivery expectations.###

The Opportunity:

* Driving department-wide engagement by fostering a culture of collaboration, inclusivity, and high performance while championing inclusion and belonging. Inspire, motivate, and develop talent within the team, ensuring a focus on individual growth and leadership development to build a strong, elevated talent pipeline aligned with organizational objectives.
* Regular year-round assessment of performance, contributions, and impact and providing feedback, coaching, and performance management.
* Manages 8-10 direct reports, including other people leaders.
* Leading by example in demonstrating and championing inclusive behaviours  in your team, PDG,  PD, and the Roche Enterprise. Provide opportunities for growth and development for all team members and address any barriers that may exist.
* People management-related administration (e.g. Workday People & Culture Management system tasks) and contact for employment-related matters.### Who You Are:
* Substantial pharmaceutical Clinical Operations experience with operations leadership at the program or asset level.
* Demonstrable operational awareness including external trends and issues in the global Clinical trials landscape, and development and delivery of large endpoint driven clinical trials
* Comprehensive understanding of global Pharma Clinical development in…